NAKA
Nakamoto Inc.
NASDAQ · Healthcare · Medical - Equipment & Services · US
$8.13
−2.17%Year over year
Reported trailing growth
- Revenue
- +1657.8%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +37.5%
- EBITDA
- +90.9%
- EPS
- +93.4%
Three-year CAGR
- Revenue
- -21.7%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026